tirzepatide during pregnancy and Pregnancy: Safety Facts Tirzepatide and Pregnancy - Tirzepatide

Information on side effects, self-monitoring blood glucose and treatment compliance were also collected

Chilton, W., & Charchar, F

What weve learned is that GLP-1 acts on widely distributed but metabolically relevant brain circuitry

Novo Nordisk developed the higher dose because, while the 2.4 mg shot has been effective, some individuals do not reach their therapeutic goals at that dose, according to a The FDA approved the higher dose version of the GLP-1 medication just 54 days after filing

At higher doses: Some participants experienced dysesthesia , an abnormal skin sensation Discontinuation rates were higher than placebo A portion of discontinuations were attributed to excessive weight loss , underscoring the importance of careful dosing and clinical oversight Additional late-stage trials are ongoing and will further clarify safety, tolerability, and optimal dosing strategies